+
+

Related Products

  • Athena Security
    5 Ratings
    Visit Website
  • MuukTest
    34 Ratings
    Visit Website
  • Omnilert
    26 Ratings
    Visit Website
  • StackAI
    53 Ratings
    Visit Website
  • Blumira
    150 Ratings
    Visit Website
  • Healthee
    13 Ratings
    Visit Website
  • ManageEngine Log360
    187 Ratings
    Visit Website
  • Code-Cube.io
    7 Ratings
    Visit Website
  • Greenhouse
    5,100 Ratings
    Visit Website
  • Imorgon
    5 Ratings
    Visit Website

About

By detecting early-stage cancers, AI enables timely management that can increase the chance of survival through AI. Cancer is complex. Every cancer is unique in its own way, containing vast information that needs to be processed. Complex is what AI does best. With its analysis that extends human capacity, AI can unlock cancer information that leads us to new revelations that can serve as a key strategy in fighting cancer. Armed with the accurate and appropriate information, we can take a step ahead in the war on cancer. Through AI, we can conquer cancer. We develop AI that detects early-stage cancer and optimizes cancer treatment. Detects with 97-99% accuracy. Accurately detects 10 of the most common findings in a chest x-ray. Improving the most basic and universal diagnostic test. Alleviating the burden in radiology workflow. Lunit INSIGHT CXR covers the vast majority of findings. Accurately detects 10 of the most common findings in a chest x-ray.

About

Recursion is a TechBio company focused on transforming drug discovery by combining biology, data, and artificial intelligence. Founded over a decade ago, the company pioneered the use of large-scale cellular imaging to train AI models that decode the biological drivers of disease. Recursion’s mission is to deliver better medicines through novel insights and precision design, reducing the high failure rates of traditional drug development. Its proprietary Recursion OS platform integrates massive biological datasets with machine learning to accelerate discovery from target identification to clinical development. The company has built an advanced pipeline of potential first-in-class and best-in-class therapies targeting aggressive cancers and rare diseases. Automated wet labs and robotics enable millions of experiments per week, feeding continuous learning into its AI models.

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Audience

Healthcare providers and clinical professionals looking for an AI solution to identify, detect, diagnose, and treat cancer in patients

Audience

Recursion is ideal for researchers, pharmaceutical partners, investors, and healthcare stakeholders interested in AI-driven drug discovery and next-generation therapeutic development

Support

Phone Support
24/7 Live Support
Online

Support

Phone Support
24/7 Live Support
Online

API

Offers API

API

Offers API

Screenshots and Videos

Screenshots and Videos

Pricing

No information available.
Free Version
Free Trial

Pricing

No information available.
Free Version
Free Trial

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Training

Documentation
Webinars
Live Online
In Person

Training

Documentation
Webinars
Live Online
In Person

Company Information

Lunit
United States
www.lunit.io/en

Company Information

Recursion
United States
www.recursion.com

Alternatives

Alternatives

The Galen Platform

The Galen Platform

Ibex Medical Analytics
Oncora

Oncora

Oncora Medical

Categories

Categories

Integrations

No info available.

Integrations

No info available.
Claim Lunit and update features and information
Claim Lunit and update features and information
Claim Recursion and update features and information
Claim Recursion and update features and information